Provider Delay in Treatment Initiation and its Influence on Survival Outcomes in Women with Operable Breast Cancer
ConclusionsThe initiation of treatment within the first 45 days of diagnosis of BrCr in women portends better survival compared with those who began treatment longer than 45 days from diagnosis.
Source: Reports of Practical Oncology and Radiotherapy - Category: Cancer & Oncology Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Hormones | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Study | Women